| Serial Number | 90272634 |
| Word Mark | KAYAK |
| Filing Date | Thursday, October 22, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, October 28, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 27, 2021 |
| Goods and Services | Providing medical information; providing medical information relating to therapies and treatments for epilepsy and central nervous system diseases and disorders |
| Goods and Services | Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of epilepsy and central nervous system diseases and disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders, and evaluating epidemiological results for treatments for epilepsy and central nervous system diseases and disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for epilepsy and central nervous system diseases and disorders |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, December 12, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, December 12, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Event Date | Event Description |
| Monday, October 26, 2020 | NEW APPLICATION ENTERED |
| Saturday, December 12, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, December 15, 2020 | ASSIGNED TO EXAMINER |
| Thursday, December 17, 2020 | NON-FINAL ACTION WRITTEN |
| Thursday, December 17, 2020 | NON-FINAL ACTION E-MAILED |
| Thursday, December 17, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, June 16, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 16, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 16, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 21, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, June 21, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Monday, June 21, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, June 21, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Monday, June 21, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 7, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 27, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 27, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 21, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, March 21, 2022 | SOU TEAS EXTENSION RECEIVED |
| Monday, March 21, 2022 | SOU EXTENSION 1 FILED |
| Monday, March 21, 2022 | SOU EXTENSION 1 GRANTED |
| Wednesday, March 23, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 30, 2022 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, August 30, 2022 | SOU EXTENSION 2 FILED |
| Tuesday, August 30, 2022 | SOU EXTENSION 2 GRANTED |
| Thursday, September 1, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, February 21, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, February 21, 2023 | SOU EXTENSION 3 FILED |
| Tuesday, February 21, 2023 | SOU EXTENSION 3 GRANTED |
| Thursday, February 23, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, September 19, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, September 19, 2023 | SOU EXTENSION 4 FILED |
| Tuesday, September 19, 2023 | SOU EXTENSION 4 GRANTED |
| Thursday, September 21, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, March 6, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, March 6, 2024 | SOU EXTENSION 5 FILED |
| Wednesday, March 6, 2024 | SOU EXTENSION 5 GRANTED |
| Thursday, March 7, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, October 28, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, October 28, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |